Go to Header Go to Navigation Go to Content Go to Footer
-
CLEVER-1 targeting antibody, bexmarilimab, supports HLA-DR expression and alters ex vivo responsiveness to azacitidine and venetoclax in myeloid malignancies (2025) Aakko, Sofia; Ylitalo, Arno; Kuusanmäki, Heikki; Rannikko, Jenna H.; Björkman, Mari; Mandelin, Jami; Heckman, Caroline A.; Kontro, Mika; Hollmén, Maija
-
-
-
-
-
-
-
Looking back at the TEDDY study: lessons and future directions (2025) - Nature Reviews Endocrinology
Lernmark, Ake; Agardh, Daniel; Akolkar, Beena; Gesualdo, Patricia; Hagopian, William A.; Haller, Michael J.; Hyoty, Heikki; Johnson, Suzanne Bennett; Larsson, Helena Elding; Liu, Edwin; Lynch, Kristian F.; Mckinney, Eoin F.; Mcindoe, Richard; Melin, Jessica; Norris, Jill M.; Rewers, Marian; Rich, Stephen S.; Toppari, Jorma; Triplett, Eric; Vehik, Kendra; Virtanen, Suvi M.; Ziegler, Anette-G.; Schatz, Desmond A.; Krischer, Jeffrey